title: Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection.
abstract: Relationships among four serologic activation markers and T cell subsets were measured in HIV-seropositive former blood donors (N = 64) and seronegative controls (N = 61). Significant correlations were observed for the HIV group in pairwise comparisons of soluble IL-2 receptor (sIL-2R), beta 2-microglobulin (beta 2M), neopterin (NEOP), and soluble CD8 (sCD8). CD4 cell levels (number/microliter) in the HIV group showed significant negative correlation with all four serologic markers; CD8 cell levels, in contrast, showed no significant correlation with any serologic activation marker measured. Significant correlations were observed, however, among various cell surface activation markers and serologic activation markers. Specifically, the proportion of CD8 cells expressing CD45RA showed significant negative correlations with NEOP and B2M levels, whereas the proportion of CD8 cells expressing HLA-DR showed significant positive correlations with B2M and sIL-2R levels. Further, the proportion of CD8 cells expressing CD38 showed significant positive correlations with all four serologic activation markers. These findings indicate that sIL-2R, B2M, NEOP, and sCD8 show similar quantitative changes and correlational relationships to CD4 cell destruction in HIV infection; they differ, however, in their relationships to proportional changes in activated CD8 cell subsets.
authors.affiliation: Cellular Immunology Laboratory, American Red Cross Blood Services, Los Angeles, California 90006.
authors.forename: H E
authors.initials: HE
authors.lastname: Prince
authors.forename: S
authors.initials: S
authors.lastname: Kleinman
authors.forename: C
authors.initials: C
authors.lastname: Czaplicki
authors.forename: J
authors.initials: J
authors.lastname: John
authors.forename: A E
authors.initials: AE
authors.lastname: Williams
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D015415:Biomarkers; D001708:Biopterins / Q000031:analogs & derivatives / Q000032:analysis / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D019798:Neopterin; D015375:Receptors, Interleukin-2 / Q000032:analysis / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D001613:beta 2-Microglobulin / Q000032:analysis / Q000276:immunology
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D015375:Receptors, Interleukin-2; D001613:beta 2-Microglobulin; D001708:Biopterins; D019798:Neopterin